Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KYMR | RGEN | ERAS | ||
| Company | Kymera Therapeutics Inc | Repligen Corp | Erasca Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 87.14 | 133.04 | 21.86 | ||
| High | 88.29 | 141.46 | 23.27 | ||
| Low | 85.49 | 131.30 | 20.70 | ||
| Latest | 88.07 | 132.70 | 22.41 | ||
| Change | +1.14 | +0.71 | +0.70 | ||
| % Change | +1.31% | +0.54% | +3.22% | ||
| Volume | 502,300 | 1,105,700 | 8,967,700 | ||
| 20-Day Average Volume | 594,800 | 845,420 | 5,565,070 | ||
| Previous Close | 86.93 | 131.99 | 21.71 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 84.55 | 121.05 | 17.28 | ||
| 20-Day Raw Stochastic | 87.67% | 72.46% | 90.86% | ||
| 20-Day Relative Strength | 56.59 | 57.17 | 76.62 | ||
| Weighted Alpha | +80.41 | -6.98 | +1,000.80 | ||
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | ||
| Previous Opinion | 88% Buy | 40% Sell | 100% Buy | ||
| Last Month's Opinion | 64% Buy | 72% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.00% since 04/14/26 | +1.27% since 04/14/26 | +25.55% since 04/14/26 | ||
| Low | 84.64 on 04/16/26 | 125.83 on 04/16/26 | 17.63 on 04/16/26 | ||
| High | 90.14 on 04/15/26 | 141.46 on 04/21/26 | 23.27 on 04/21/26 | ||
| 1-Month | |||||
| %Chg | +13.04% since 03/20/26 | +16.53% since 03/20/26 | +53.49% since 03/20/26 | ||
| Low | 73.31 on 03/24/26 | 109.66 on 03/27/26 | 13.86 on 03/24/26 | ||
| High | 90.14 on 04/15/26 | 141.46 on 04/21/26 | 23.27 on 04/21/26 | ||
| 3-Month | |||||
| %Chg | +24.50% since 01/21/26 | -21.93% since 01/21/26 | +122.99% since 01/21/26 | ||
| Low | 68.29 on 01/26/26 | 109.66 on 03/27/26 | 9.05 on 01/26/26 | ||
| High | 95.90 on 02/26/26 | 174.87 on 01/22/26 | 23.27 on 04/21/26 | ||
| 6-Month | |||||
| %Chg | +51.01% since 10/21/25 | -15.34% since 10/21/25 | +841.60% since 10/21/25 | ||
| Low | 55.26 on 10/23/25 | 109.66 on 03/27/26 | 2.11 on 11/07/25 | ||
| High | 103.00 on 12/08/25 | 175.77 on 01/06/26 | 23.27 on 04/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,097,138 | 7,444,103 | 6,747,468 | ||
| Shares Outstanding, K | 81,642 | 56,399 | 310,800 | ||
| Annual Sales | 39,210,000 | 738,260,000 | 0 | ||
| Annual Net Income | -311,350,000 | 48,890,000 | -124,550,000 | ||
| Last Quarter Sales | 2,870,000 | 197,910,000 | 0 | ||
| Last Quarter Net Income | -86,980,000 | 13,290,000 | -29,090,000 | ||
| 60-Month Beta | 2.28 | 1.19 | 1.04 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.97 on 02/26/26 | 0.49 on 02/24/26 | -0.10 on 03/12/26 | ||
| Latest Earnings Date | 05/08/26 | 05/05/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 76.73 | 0.00 | ||